These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8900527

  • 1. [Remission of schizophrenic psychosis with negative symptoms with risperidone].
    Lübbe R.
    Fortschr Med; 1996 Feb 28; 114(6):35-6. PubMed ID: 8900527
    [Abstract] [Full Text] [Related]

  • 2. Pathophysiology and treatment of negative symptoms.
    Villeneuve A.
    Can J Psychiatry; 1994 Nov 28; 39(9 Suppl 2):S53-8. PubMed ID: 7533052
    [Abstract] [Full Text] [Related]

  • 3. [New chemotherapy approaches to psychoses].
    Olié JP, Baylé FJ.
    Encephale; 1997 Apr 28; 23 Spec No 2():2-9. PubMed ID: 9273302
    [Abstract] [Full Text] [Related]

  • 4. [Initial use of risperidone in the treatment of acutely exacerbated schizophrenic patients--an interim analysis].
    Pajonk FG, Schreiner A, Peters S, Rettig K, Degner D, Rüther E.
    Fortschr Neurol Psychiatr; 2003 May 28; 71(5):249-54. PubMed ID: 12740756
    [Abstract] [Full Text] [Related]

  • 5. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec 28; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 6. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE.
    J Clin Psychiatry; 2001 Dec 28; 62 Suppl 21():29-32. PubMed ID: 11584986
    [Abstract] [Full Text] [Related]

  • 7. [Profile of the action of neuroleptics in deficit schizophrenia].
    Vanelle JM.
    Encephale; 1996 Jun 28; 22 Spec No 2():33-9. PubMed ID: 8767040
    [Abstract] [Full Text] [Related]

  • 8. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H.
    Int J Geriatr Psychiatry; 2007 May 28; 22(5):475-84. PubMed ID: 17471598
    [Abstract] [Full Text] [Related]

  • 9. [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
    Philipp M, Lesch OM, Schmauss M, Dose M, Glaser T.
    Psychiatr Prax; 2003 May 28; 30 Suppl 2():S94-6. PubMed ID: 14509050
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M, Kuwilsky A, Krumm B, Dressing H.
    J Psychopharmacol; 2009 May 28; 23(3):305-14. PubMed ID: 18562423
    [Abstract] [Full Text] [Related]

  • 11. Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia.
    Roesch-Ely D, Göhring K, Gruschka P, Kaiser S, Pfüller U, Burlon M, Weisbrod M.
    Pharmacopsychiatry; 2006 May 28; 39(3):115-6. PubMed ID: 16721703
    [Abstract] [Full Text] [Related]

  • 12. Assessing the effects of atypical antipsychotics on negative symptoms. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998 May 28; 59 Suppl 12():28-34. PubMed ID: 9766617
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP, Eerdekens E, Berry SA, Eerdekens M.
    J Clin Psychiatry; 2004 Aug 28; 65(8):1084-9. PubMed ID: 15323593
    [Abstract] [Full Text] [Related]

  • 14. Maintenance electroconvulsive therapy combined with long-acting risperidone in the treatment of resistant bipolar affective disorder.
    Sengul C, Kalkanci O, Simsek D, Herken H.
    J ECT; 2009 Dec 28; 25(4):282-3. PubMed ID: 19440160
    [Abstract] [Full Text] [Related]

  • 15. Risperidone for negative symptoms.
    Zuddas A, Pintor M, Cianchetti C.
    J Am Acad Child Adolesc Psychiatry; 1996 Jul 28; 35(7):838-9. PubMed ID: 8768338
    [No Abstract] [Full Text] [Related]

  • 16. [Ziprasidone-augmentation of clozapine].
    Zink M, Mase E, Dressing H.
    Psychiatr Prax; 2004 Jul 28; 31(5):259-61. PubMed ID: 15243877
    [Abstract] [Full Text] [Related]

  • 17. Risperidone in acute and long-term therapy of schizophrenia--a clinical profile.
    Pajonk FG.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan 28; 28(1):15-23. PubMed ID: 14687852
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms.
    Ruhrmann S, Kissling W, Lesch OM, Schmauss M, Seemann U, Philipp M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1012-22. PubMed ID: 17412473
    [Abstract] [Full Text] [Related]

  • 19. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
    Kim SW, Shin IS, Kim JM, Lee SH, Lee JH, Yoon BH, Yang SJ, Hwang MY, Yoon JS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1504-9. PubMed ID: 17692448
    [Abstract] [Full Text] [Related]

  • 20. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV, Montejo González AL, Martín Carrasco M.
    Actas Esp Psiquiatr; 2003 Oct 01; 31(6):347-52. PubMed ID: 14639511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.